MANGROVE PARTNERS latest Q4_2020 13F filings reported $730,702,000 in market value on this 2021-02-16 report date . The portfolio quarterly return is -5.13%. This fund has 100 securities concentrations of 100% weights.
MANGROVE PARTNERS largest holding is TG Therapeutics Inc. with weight of 2.42% and $17,679,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.
Portfolio Performance History
|FILE DATE||REPORT PERIOD||QTR YEAR||FILE TYPE||NOS. OF STOCKS||REPORTED VALUE||RETURN|